share_log

科濟藥業-B：翌日披露報表

CARSGEN-B: Next Day Disclosure Return

HKEX ·  Jun 25 20:20

Summary by Moomoo AI

科濟藥業-B（02171.HK）於2024年6月25日提交了翌日披露報表，披露其股份回購情況。根據報表，公司於2024年5月31日至6月25日期間，透過香港聯合交易所有限公司（香港聯交所）進行了多次股份回購，合計回購股份數目為3,985,500股，佔已發行股份的0.692%。最新一次回購發生在2024年6月25日，當日回購145,500股，每股購回價介乎HKD 4.9至HKD 4.94，總付出價格為HKD 716,150。該公司確認，所有回購均按照相關上市規則及法律規定進行，並已獲得董事會的正式授權。此外，公司於2024年5月21日獲得股份回購授權，可回購的股份總數為57,564,391股。根據規定，公司在完成股份回購後的30天內，將不會進行任何新股發行或庫存股份再出售或轉讓，該暫止期將持續至2024年7月25日。
科濟藥業-B（02171.HK）於2024年6月25日提交了翌日披露報表，披露其股份回購情況。根據報表，公司於2024年5月31日至6月25日期間，透過香港聯合交易所有限公司（香港聯交所）進行了多次股份回購，合計回購股份數目為3,985,500股，佔已發行股份的0.692%。最新一次回購發生在2024年6月25日，當日回購145,500股，每股購回價介乎HKD 4.9至HKD 4.94，總付出價格為HKD 716,150。該公司確認，所有回購均按照相關上市規則及法律規定進行，並已獲得董事會的正式授權。此外，公司於2024年5月21日獲得股份回購授權，可回購的股份總數為57,564,391股。根據規定，公司在完成股份回購後的30天內，將不會進行任何新股發行或庫存股份再出售或轉讓，該暫止期將持續至2024年7月25日。
Keejia Pharmaceutical-B (02171.HK) submitted its disclosure report for the following day on June 25, 2024, disclosing its share buyback situation. According to the report, the company conducted several share buybacks through the Hong Kong Stock Exchange (HKSE) from May 31, 2024 to June 25, 2024, with a total repurchase of 3,985,500 shares, accounting for 0.692% of the issued shares. The latest buyback occurred on June 25, 2024, with a repurchase of 145,500 shares at a price range between HKD 4.9 and HKD 4.94 per share, with a total payment of HKD 716,150. The company confirmed that all repurchases were carried out in accordance with relevant listing rules and legal regulations, and have received the formal authorization of the board of directors. In addition, the company obtained a share buyback authorization on May 21, 2024, and the total number of shares that can be repurchased is 57,564,391. According to regulations, the company will not conduct any new share issuances or inventory share resales or transfers within 30 days after completing share buybacks, and this suspension period will continue until July 25, 2024.
Keejia Pharmaceutical-B (02171.HK) submitted its disclosure report for the following day on June 25, 2024, disclosing its share buyback situation. According to the report, the company conducted several share buybacks through the Hong Kong Stock Exchange (HKSE) from May 31, 2024 to June 25, 2024, with a total repurchase of 3,985,500 shares, accounting for 0.692% of the issued shares. The latest buyback occurred on June 25, 2024, with a repurchase of 145,500 shares at a price range between HKD 4.9 and HKD 4.94 per share, with a total payment of HKD 716,150. The company confirmed that all repurchases were carried out in accordance with relevant listing rules and legal regulations, and have received the formal authorization of the board of directors. In addition, the company obtained a share buyback authorization on May 21, 2024, and the total number of shares that can be repurchased is 57,564,391. According to regulations, the company will not conduct any new share issuances or inventory share resales or transfers within 30 days after completing share buybacks, and this suspension period will continue until July 25, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated